AAAAAA

   
Results: 1-8 |
Results: 8
Human liver quality is a dominant factor in the outcome of in vitro studies
Authors: Fisher, RL Gandolfi, AJ Brendel, K
Citation: Rl. Fisher et al., Human liver quality is a dominant factor in the outcome of in vitro studies, CELL BIOL T, 17(3), 2001, pp. 179-189
Correlation between self-reported adherence to highly active antiretroviral therapy (HAART) and virologic outcome
Authors: DeMasi, RA Graham, NM Tolson, JM Pham, SV Capuano, GA Fisher, RL Shaefer, MS Pakes, GE Sawyerr, GA Eron, JJ
Citation: Ra. Demasi et al., Correlation between self-reported adherence to highly active antiretroviral therapy (HAART) and virologic outcome, ADV THER, 18(4), 2001, pp. 163-173
Twice-daily triple nucleoside intensification treatment with lamivudine-zidovudine plus abacavir sustains suppression of human immunodeficiency virustype 1: Results of the TARGET study
Authors: Henry, K Wallace, RJ Bellman, PC Norris, D Fisher, RL Ross, LL Liao, QM Shaefer, MS
Citation: K. Henry et al., Twice-daily triple nucleoside intensification treatment with lamivudine-zidovudine plus abacavir sustains suppression of human immunodeficiency virustype 1: Results of the TARGET study, J INFEC DIS, 183(4), 2001, pp. 571-578
Efficacy, safety, and adherence with a twice-daily combination lamivudine/zidovudine tablet formulation, plus a protease inhibitor, in HIV infection (vol 14, pg 671, 2000)
Authors: Eron, JJ Yetzer, ES Ruane, PJ Becker, S Sawyerr, GA Fisher, RL Tolson, JM Shaefer, MS
Citation: Jj. Eron et al., Efficacy, safety, and adherence with a twice-daily combination lamivudine/zidovudine tablet formulation, plus a protease inhibitor, in HIV infection (vol 14, pg 671, 2000), AIDS, 14(9), 2000, pp. 1295-1295
Efficacy, safety, and adherence with a twice-daily combination lamivudine/zidovudine tablet formulation, plus a protease inhibitor, in HIV infection
Authors: Eron, JJ Yetzer, ES Ruane, PJ Becker, S Sawyerr, GA Fisher, RL Tolson, JM Shaefer, MS
Citation: Jj. Eron et al., Efficacy, safety, and adherence with a twice-daily combination lamivudine/zidovudine tablet formulation, plus a protease inhibitor, in HIV infection, AIDS, 14(6), 2000, pp. 671-681
Cytochrome P-450-dependent bioactivation of 1,1 -dichloroethylene to a reactive epoxide in human lung and liver microsomes
Authors: Dowsley, TF Reid, K Petsikas, D Ulreich, JB Fisher, RL Forkert, PG
Citation: Tf. Dowsley et al., Cytochrome P-450-dependent bioactivation of 1,1 -dichloroethylene to a reactive epoxide in human lung and liver microsomes, J PHARM EXP, 289(2), 1999, pp. 641-648
Wasting in chronic gastrointestinal diseases
Authors: Fisher, RL
Citation: Rl. Fisher, Wasting in chronic gastrointestinal diseases, J NUTR, 129(1), 1999, pp. 252S-255S
The physiography of the southwest Indian ridge (vol 20, pg 451, 1998)
Authors: Fisher, RL Goodwillie, AM
Citation: Rl. Fisher et Am. Goodwillie, The physiography of the southwest Indian ridge (vol 20, pg 451, 1998), MAR GEOPHYS, 20(3), 1998, pp. 249-249
Risultati: 1-8 |